BioPorto A/S 2023 Annual Report with Sustainability Disclosures
Company: BioPorto A/S
Sector: Professional & technical services
Country: Denmark
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 80
The report describes BioPorto's December 2023 FDA clearance of the NGAL test for pediatric and young adult use and a 2024-2029 growth strategy. It reports 2023 consolidated revenue of DKK 31.0 million and a leaner organization while preparing for commercialization. The CSR section documents adherence to the UN Global Compact, zero reported human-rights violations, and a 61% female workforce. The BioPorto A/S Board had one female member out of five, or 20%.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.